Literature DB >> 25436495

Retinoblastoma: evidence for postenucleation adjuvant chemotherapy.

Jonathan W Kim.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25436495     DOI: 10.1097/IIO.0000000000000048

Source DB:  PubMed          Journal:  Int Ophthalmol Clin        ISSN: 0020-8167


× No keyword cloud information.
  4 in total

Review 1.  Retinoblastoma.

Authors:  Helen Dimaras; Timothy W Corson; David Cobrinik; Abby White; Junyang Zhao; Francis L Munier; David H Abramson; Carol L Shields; Guillermo L Chantada; Festus Njuguna; Brenda L Gallie
Journal:  Nat Rev Dis Primers       Date:  2015-08-27       Impact factor: 52.329

2.  High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer Study.

Authors:  Ankit Singh Tomar; Paul T Finger; Brenda Gallie; Tero T Kivelä; Ashwin Mallipatna; Chengyue Zhang; Junyang Zhao; Matthew W Wilson; Rachel C Brennan; Michala Burges; Jonathan Kim; Jesse L Berry; Rima Jubran; Vikas Khetan; Suganeswari Ganesan; Andrey Yarovoy; Vera Yarovaya; Elena Kotova; Denis Volodin; Yacoub A Yousef; Kalle Nummi; Tatiana L Ushakova; Olga V Yugay; Vladimir G Polyakov; Marco A Ramirez-Ortiz; Elizabeth Esparza-Aguiar; Guillermo Chantada; Paula Schaiquevich; Adriana Fandino; Jason C Yam; Winnie W Lau; Carol P Lam; Phillipa Sharwood; Sonia Moorthy; Quah Boon Long; Vera Adobea Essuman; Lorna A Renner; Ekaterina Semenova; Jaume Català-Mora; Genoveva Correa-Llano; Elisa Carreras
Journal:  Ophthalmology       Date:  2022-04-15       Impact factor: 14.277

3.  Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion?

Authors:  Jesse L Berry; Emily Zolfaghari; Alexander Chen; A Linn Murphree; Rima Jubran; Jonathan W Kim
Journal:  Ocul Oncol Pathol       Date:  2017-04-07

Review 4.  Long noncoding RNAs as potential biomarkers in retinoblastoma: a systematic review and meta-analysis.

Authors:  Jiali Wu; Dashi Qian; Xiaodong Sun
Journal:  Cancer Cell Int       Date:  2020-05-29       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.